WallStreetZenWallStreetZen

NASDAQ: ATAI
Atai Life Sciences Nv Stock

$1.77+0.00 (+0%)
Updated May 26, 2023
ATAI Price
$1.77
Fair Value Price
N/A
Market Cap
$293.84M
52 Week Low
$1.14
52 Week High
$4.96
P/E
-1.84x
P/B
1.24x
P/S
1,048.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$269.00k
Earnings
-$148.65M
Gross Margin
100%
Operating Margin
-52,667.66%
Profit Margin
-55,260.6%
Debt to Equity
0.17
Operating Cash Flow
-$102M
Beta
1.37
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ATAI Overview

Atai Life Sciences N.V. is a clinical-stage biopharmaceutical company developing various therapeutic candidates that focus on various mental health disorders including depression, substance use disorder, and anxiety. The company's pipeline includes PCN-101, RL-007, DMX-1002, GRX-917, NN-101, VLS-01, EMP-01, RLS-01, DMX-1001, and others. Formerly known as Adripa Holding B.V., Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ATAI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ATAI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ATAI is good value based on its book value relative to its share price (1.24x), compared to the US Biotechnology industry average (5.18x)
P/B vs Industry Valuation
ATAI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ATAI due diligence checks available for Premium users.

Be the first to know about important ATAI news, forecast changes, insider trades & much more!

ATAI News

Valuation

ATAI fair value

Fair Value of ATAI stock based on Discounted Cash Flow (DCF)
Price
$1.77
Fair Value
$2.39
Undervalued by
25.95%
ATAI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ATAI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.84x
Industry
11.86x
Market
54.23x

ATAI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.24x
Industry
5.18x
ATAI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ATAI's financial health

Profit margin

Revenue
$37.0k
Net Income
-$33.1M
Profit Margin
-89,554.1%
ATAI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ATAI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$280.7M
Liabilities
$40.1M
Debt to equity
0.17
ATAI's short-term assets ($267.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATAI's short-term assets ($267.93M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATAI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$21.1M
Investing
$16.0M
Financing
$206.0k
ATAI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ATAI vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ATAI$293.84M0.00%-1.84x1.24x
STRO$296.04M-3.16%-2.06x1.60x
PHVS$291.62M+1.41%-3.19x2.05x
SVRA$303.42M+3.10%-9.85x3.09x
CABA$282.83M-4.25%-4.98x3.09x

Atai Life Sciences Nv Stock FAQ

What is Atai Life Sciences Nv's quote symbol?

(NASDAQ: ATAI) Atai Life Sciences Nv trades on the NASDAQ under the ticker symbol ATAI. Atai Life Sciences Nv stock quotes can also be displayed as NASDAQ: ATAI.

If you're new to stock investing, here's how to buy Atai Life Sciences Nv stock.

What is the 52 week high and low for Atai Life Sciences Nv (NASDAQ: ATAI)?

(NASDAQ: ATAI) Atai Life Sciences Nv's 52-week high was $4.96, and its 52-week low was $1.14. It is currently -64.31% from its 52-week high and 55.26% from its 52-week low.

How much is Atai Life Sciences Nv stock worth today?

(NASDAQ: ATAI) Atai Life Sciences Nv currently has 166,010,476 outstanding shares. With Atai Life Sciences Nv stock trading at $1.77 per share, the total value of Atai Life Sciences Nv stock (market capitalization) is $293.84M.

Atai Life Sciences Nv stock was originally listed at a price of $19.45 in Jun 18, 2021. If you had invested in Atai Life Sciences Nv stock at $19.45, your return over the last 1 years would have been -90.9%, for an annualized return of -90.9% (not including any dividends or dividend reinvestments).

How much is Atai Life Sciences Nv's stock price per share?

(NASDAQ: ATAI) Atai Life Sciences Nv stock price per share is $1.77 today (as of May 26, 2023).

What is Atai Life Sciences Nv's Market Cap?

(NASDAQ: ATAI) Atai Life Sciences Nv's market cap is $293.84M, as of May 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Atai Life Sciences Nv's market cap is calculated by multiplying ATAI's current stock price of $1.77 by ATAI's total outstanding shares of 166,010,476.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.